Search Results - "Burman, Joachim"

Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis.

Authors: Kalincik, Tomas Sharmin, Sifat Roos, Izanne et al.

Source: Brain: A Journal of Neurology; Mar2026, Vol. 149 Issue 3, p951-962, 12p

Antibody‐positive autoimmune encephalitis and paraneoplastic neurological syndrome: A Swedish case series.

Authors: Kosek, Sonja Burman, Joachim Punga, Anna Rostedt

Source: Brain & Behavior. May2024, Vol. 14 Issue 5, p1-12. 12p.

Antibody-Positive Autoimmune Encephalitis and Paraneoplastic Neurological Syndrome: Epidemiology and Outcome of Neuronal Antibody Testing in Sweden.

Authors: Kosek, Sonja Persson, Barbro Rodrigues, Rui et al.

Source: Acta Neurologica Scandinavica. 4/10/2023, p1-9. 9p.

Subjects: Antibody titer, Paraneoplastic syndromes, Encephalitis, Epidemiology, Anti-NMDA receptor encephalitis, Medical care

Geographic Terms: Sweden

Temporal trends of epilepsy in multiple sclerosis.

Authors: Mahamud, Zamzam Burman, Joachim Zelano, Johan

Source: Acta Neurologica Scandinavica. Nov2022, Vol. 146 Issue 5, p492-498. 7p.

Subjects: Multiple sclerosis, Epilepsy, Age of onset, Diagnosis of epilepsy, Seizures (Medicine)

Urokinase, CX3CL1, CCL2, TRAIL and IL‐18 induced by interferon‐β treatment.

Authors: Zhukovsky, Christina Herman, Stephanie Wiberg, Anna et al.

Source: Acta Neurologica Scandinavica. Jun2021, Vol. 143 Issue 6, p602-607. 6p.

Subjects: Urokinase, Blood proteins, Interferon beta-1a, Interferons

Sustained remission in multiple sclerosis after hematopoietic stem cell transplantation.

Authors: Tolf, Andreas Fagius, Jan Carlson, Kristina et al.

Source: Acta Neurologica Scandinavica. Nov2019, Vol. 140 Issue 5, p320-327. 8p.

Subjects: Hematopoietic stem cell transplantation, Multiple sclerosis, Hematopoietic stem cells, Cerebrospinal fluid

Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease.

Authors: Niemelä, Valter Burman, Joachim Blennow, Kaj et al.

Source: PLoS ONE. 2/23/2018, Vol. 13 Issue 2, p1-11. 11p.

This result is not displayed to guests.
Login for full access.

T-cell responses after haematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis.

Authors: Burman, Joachim Fransson, Moa Tötterman, Thomas H. et al.

Source: Immunology. Oct2013, Vol. 140 Issue 2, p211-219. 9p.

T regulatory cells lacking CD25 are increased in MS during relapse.

Authors: Fransson, Moa Burman, Joachim Lindqvist, Camilla et al.

Source: Autoimmunity. Dec2010, Vol. 43 Issue 8, p590-597. 8p. 1 Chart, 7 Graphs.

Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension.

Authors: Bergman, Joakim Burman, Joachim Bergenheim, Tommy et al.

Source: Journal of Neurology. Feb2021, Vol. 268 Issue 2, p651-657. 7p.

Comparative effectiveness of dimethyl fumarate as the initial and secondary treatment for MS.

Authors: Granqvist, Mathias Burman, Joachim Gunnarsson, Martin et al.

Source: Multiple Sclerosis Journal. Oct2020, Vol. 26 Issue 12, p1532-1539. 8p.

Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study.

Authors: Tolf, Andreas Gauffin, Helena Burman, Joachim et al.

Source: PLoS ONE. 2/7/2024, Vol. 19 Issue 2, p1-23. 23p.

This result is not displayed to guests.
Login for full access.

The MMP‐9/TIMP‐1 Ratio and Concentrations of Osteopontin Are Elevated in Cerebrospinal Fluid of People With Multiple Sclerosis and Decrease After Autologous Hematopoietic Stem Cell Transplantation.

Authors: Pavlovic, Ivan Erngren, Ida Kultima, Kim et al.

Source: Annals of Clinical & Translational Neurology. Mar2026, Vol. 13 Issue 3, p442-452. 11p.

This result is not displayed to guests.
Login for full access.

Predictors of Ability to Work in Multiple Sclerosis.

Authors: Wellhagen, Gustaf J. Ueckert, Sebastian Nielsen, Elisabet et al.

Source: CPT: Pharmacometrics & Systems Pharmacology. Dec2025, Vol. 14 Issue 12, p2244-2251. 8p.

Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis.

Authors: Burman, Joachim Svenningsson, Anders

Source: Journal of Neuroimmunology. Mar2016, Vol. 292, p40-44. 5p.

YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis.

Authors: Burman, Joachim Raininko, Raili Blennow, Kaj et al.

Source: Journal of Neuroimmunology. Mar2016, Vol. 292, p52-57. 6p.

The cerebrospinal fluid cytokine signature of multiple sclerosis: A homogenous response that does not conform to the Th1/Th2/Th17 convention.

Authors: Burman, Joachim Svensson, Emma Fransson, Moa et al.

Source: Journal of Neuroimmunology. Dec2014, Vol. 277 Issue 1/2, p153-159. 7p.